- SECOND QUARTER REVENUE OF $130.6
MILLION, UP SLIGHTLY SEQUENTIALLY AND
YEAR-OVER-YEAR
- SECOND QUARTER OPERATING INCOME OF $16.0 MILLION; EX-ITEMS, $16.4 MILLION, UP 10% SEQUENTIALLY AND 5%
YEAR-OVER-YEAR
- SECOND QUARTER OPERATING MARGINS, EX-ITEMS, OF 13%
- SECOND QUARTER GAAP EPS OF $0.19; EX-ITEMS, $0.22, UP 16% SEQUENTIALLY AND 5%
YEAR-OVER-YEAR
- SECOND QUARTER FREE CASH FLOW OF $14.3 MILLION; NET DEBT REDUCED BY $15.8 MILLION
- COMPANY ANNOUNCES Q3 2024 QUARTERLY DIVIDEND
HOUSTON, July 24,
2024 /PRNewswire/ -- Core Laboratories Inc. (NYSE:
"CLB") ("Core", "Core Lab", or the "Company") reported second
quarter 2024 revenue of $130,600,000. Core's operating income was
$16,000,000, with diluted earnings
per share ("EPS") of $0.19, all in
accordance with U.S. generally accepted accounting principles
("GAAP"). Operating income, ex-items, a non-GAAP financial measure,
was $16,400,000, yielding operating
margins of 13%, expanding over 100 basis points sequentially, and
EPS, ex-items, of $0.22. A full
reconciliation of non-GAAP financial measures is included in the
attached financial tables.
Core's CEO, Larry Bruno stated,
"Core Lab revenue was up slightly sequentially, but our team
delivered nice improvements in operating income, operating margins,
incremental margins, free cash flow and earnings per share for the
Company. Demand for our Reservoir Description services
continued to grow across our international laboratory network
despite continuing headwinds from on-going geopolitical
conflicts. In Production Enhancement, revenue was down
slightly sequentially, mostly related to lower international
product sales, which offset the strong growth in the U.S.
However, Production Enhancement margins expanded sequentially as
savings from cost reductions and improvements in efficiencies were
achieved. Personal face-to-face meetings with Middle Eastern
operators during the second quarter reinforced continuing growth
opportunities for both of Core's operating segments as an
anticipated multi-year cycle of expanded client project activity
unfolds across the region. Core's free cash flow improved
significantly quarter-over-quarter and in addition to paying our
quarterly dividend, we applied free cash to debt reduction.
Core will continue to remain focused on executing its strategic
business initiatives while also reducing our debt leverage ratio,
which declined from 1.76 at the end of the first quarter to 1.66 at
the end of the second quarter, the lowest level in over five
years."
Reservoir Description
Reservoir Description operations are closely correlated with
trends in international and offshore activity levels, with
approximately 80% of revenue sourced from projects originating
outside the U.S. Revenue in the second quarter of 2024 was
$86,300,000, up 2% sequentially and
an increase of 3% from last year. Operating income on a GAAP basis
was $11,400,000, while operating
income, ex-items, was $11,800,000,
yielding operating margins of 14% with incremental margins of
18%. The second quarter of 2024
marks the sixth consecutive quarter of year-over-year growth
for both revenue and operating income, ex-items. The
segment's financial performance in the second quarter reflects a
continued increase in demand for reservoir rock and fluid analysis
across the Company's global operations. However, the
segment's incremental margins were adversely impacted by on-going
geopolitical disruptions and, sequentially, by absorption of higher
corporate general and administrative expenses.
In the second quarter of 2024, Core Lab was engaged by an
international operating company to determine the productive
potential of recent natural gas discoveries offshore North Sumatra, Indonesia. Core Lab
utilized its proprietary Dual Energy Computed Tomography to
expedite this core analysis program by providing early-time
assessments of lithologic properties and reservoir quality.
Most importantly for this project, a comprehensive,
three-dimensional fracture analysis was conducted and the
abundance, type, and orientation of naturally occurring fractures
were documented and interpreted. When dealing with lower
reservoir quality rock where matrix permeability restricts
hydrocarbon production rates, understanding the natural fracture
system is critical to assessing the productive potential of the
strata. The fracture study will also assist the operator in
optimizing the locations and orientation of future wells. The
cores are also undergoing a full suite of traditional physical
laboratory measurements, which will yield the key hard data points
for the operator's reservoir model.
Also in the second quarter of 2024, Core Laboratories' fluid
specialists were commissioned by a Middle Eastern National Oil
Company ("NOC") to conduct a coordinated, large-scale, surface
sampling and laboratory analysis program to investigate emulsion
problems. Water is a common byproduct of crude oil production
and occurs as either "free" water, that readily settles in surface
separators, or as dispersed droplets in the oil, known as an
emulsion. Emulsions cause various reservoir, transportation, and
processing facility-related challenges that require mitigation,
usually in an Emulsion Treatment Plant ("ETP"). ETP's use
techniques such as heating, chemical breakers and demulsifiers to
disassociate the water from the oil. The problems with emulsions
are compounded when multiple producing wells with varying
water-cuts feed into a single production stream. This makes it
difficult to identify the primary contributors to the
emulsion-related issues. The NOC's wells in the area of
concern are connected through transportation lines that feed into a
central hub and, eventually, to an onshore processing
facility. Core's analytical program identified the
problematic wells and mixing locations, leading to the generation
of a comprehensive risk map. These data are being used by the
operator to evaluate the feasibility of isolating problematic wells
and minimizing the impact on production while a longer-term
mitigation strategy is developed.
Production Enhancement
Production Enhancement operations, which are focused on complex
completions in unconventional oil and gas reservoirs in the U.S.,
as well as conventional and unconventional projects across the
globe, posted second quarter 2024 revenue of $44,300,000, down slightly sequentially and flat
year-over-year. Operating income on a GAAP basis was
$4,400,000, while operating income,
ex-items, was $4,500,000, yielding
operating margins of 10%, an improvement of 260 basis points,
sequentially. The financial performance reflects both
on-going demand for completion diagnostic services, as well as
improved penetration of completion products in the U.S., despite
completion activity starting to soften in the back half of the
quarter.
During the second quarter of 2024, an onshore U.S. operator
engaged Core's Production Enhancement engineers when a saltwater
disposal well failed state-mandated Mechanical Integrity Testing
("MIT"). It was determined that a
220-foot section of casing was damaged and leaking well-bore
fluid. Core's well remediation experts quickly identified a
solution using the Company's proprietary X-SPAN® system, a
technology that is designed for remediating damaged pipe. The
X-SPAN® system utilizes proprietary and patented metal-to-metal
technologies and provides a durable seal for compromised
casing. After the X-SPAN® technology was deployed, an
MIT retest confirmed that the desired
results had been achieved. The well was brought back online
and saltwater disposal operations resumed within 24 hours of the
remediation program.
Also in the second quarter of 2024, a deepwater Gulf of Mexico operator employed Core's
SpectraStim® proppant tracers, SpectraScan™ gamma ray logging, and
PackScan™ density logging technologies to evaluate the
effectiveness of their frac pack completion. This frac pack
operation was conducted on a legacy platform, over a highly
productive, but relatively thin sandstone interval. The
completion needed to be performed flawlessly and within the
project's economic constraints. Unexpected operational issues
occurred during the frac pack placement. These led to a
cautionary restress of the annular pack, but also created concerns
about the integrity of the completion. To assess the
competency of the frac pack, the operator employed Core's
completion diagnostic logging technologies, which Core's
engineering team expeditiously processed to minimize well
costs. The SpectraScan™ and PackScan™ logs confirmed an
effective frac pack placement with no voids in the annular pack and
a substantial proppant reserve above the sand control screen.
Upon receiving Core's verification, the operator confidently ran
production tubing in advance of bringing the well online.
Liquidity, Free Cash Flow and Dividend
Core continues to focus on maximizing free cash flow ("FCF"), a
non-GAAP financial measure defined as cash from operations less
capital expenditures. For the second quarter of 2024, cash
from operations was approximately $17,200,000 and capital expenditures were
$2,900,000, yielding FCF of
$14,300,000. The Company
generated $16,800,000 of FCF for the
six months ended June 30, 2024, which
increased from $1,200,000 for the
same period in the prior year. The improvement in FCF
generated during 2024 is primarily associated with a lower
investment in working capital with continued improvements in
managing inventory.
Core expects the Company to continue generating positive free
cash flow in future quarters. As of June 30, 2024,
Core's net debt (defined as long term debt less cash and cash
equivalents) was $132,300,000, which
was reduced by $15,800,000 during the
quarter. The Company's leverage ratio of 1.66 also improved
from prior quarter-end of 1.76. The Company will continue
applying future free cash towards reducing debt until the Company
reaches its target leverage ratio (calculated as total net debt
divided by trailing twelve months adjusted EBITDA) of 1.5 times or
lower.
On April 24, 2024, Core's Board of
Directors ("Board") announced a quarterly cash dividend of
$0.01 per share of common stock,
which was paid on May 28, 2024 to
shareholders of record on May 6,
2024.
On July 24, 2024, the Board
approved a cash dividend of $0.01 per
share of common stock payable on August 26,
2024 to shareholders of record on August 5, 2024.
Return On Invested Capital
The Board and the Company's Executive Management continue to
focus on strategies that maximize return on invested capital
("ROIC") and FCF, factors that have high correlation to total
shareholder return. Core's commitment to an asset-light
business model and disciplined capital stewardship promotes capital
efficiency and are designed to produce more predictable and
superior long-term ROIC.
The Board has established an internal metric to demonstrate ROIC
performance relative to the oilfield service companies listed as
Core's Comp Group by Bloomberg, as the Company continues to believe
superior ROIC will result in higher total shareholder return.
Using Bloomberg's formula, the Company's ROIC as of June 30, 2024 was 8.0%.
Industry and Core Lab Outlook and Guidance
Core Lab maintains its constructive outlook on international
upstream projects for 2024 and anticipates sustainable client
activity growth in the years ahead to support rising crude-oil
demand and energy security concerns. Aligned with this, Core
will continue to execute its strategic plan of technology
investments and pursue growth opportunities. IEA, EIA and
OPEC projections continue to forecast growth in crude-oil demand of
between one and two million barrels per day for both 2024 and
2025. The projected growth in crude-oil demand is in addition
to the natural decline of production from existing fields. As
such, continued investment in the development of onshore and
offshore crude-oil fields will be required to meet the projected
growth in demand. In the near-term, crude-oil markets will
remain volatile due to global economic and geopolitical risks and
uncertainties.
As international project activity continues to expand, committed
long-term upstream projects from the Middle East, South Atlantic Margin, certain
areas of Asia Pacific and
West Africa support year-over-year
growth in demand for Core Lab's services and products.
However, as the third quarter began, demand for laboratory assay
work was negatively impacted by military attacks on hydrocarbon
refining infrastructure and the maritime transportation network in
the Russia-Ukraine region, along with a temporary closure
of client facilities and ports in the Gulf of Mexico due to Hurricane Beryl.
In addition, the Company anticipates U.S. onshore client activity
will be sequentially lower. Consequently, Core projects
Reservoir Description's third quarter 2024 revenue to grow
modestly. Turning to Production Enhancement, the U.S. frac
spread count continues to trend lower and the Company anticipates a
soft market for the remainder of the year. However, growth in
demand for Core's international and offshore diagnostic services
and energetic system product sales should offset declines in U.S.
onshore activity.
Reservoir Description's third quarter 2024 revenue is projected
to range from $86,500,000 to
$89,500,000, with operating income of
$13,400,000 to $14,000,000. Core's Production Enhancement
segment's third quarter 2024 revenue is estimated to range from
$44,500,000 to $47,500,000, with operating income of
$3,300,000 to $4,900,000.
The Company's third quarter 2024 revenue is projected to range
from $131,000,000 to $137,000,000, with operating income of
$16,900,000 to $19,100,000, yielding operating margins of
approximately 13%. EPS for the third quarter of 2024 is
expected to be $0.23 to $0.27.
The Company's third quarter 2024 guidance is based on
projections for underlying operations and excludes gains and losses
in foreign exchange. Third quarter 2024 guidance also assumes an
effective tax rate of 20%.
Earnings Call Scheduled
The Company has scheduled a conference call to discuss Core's
second quarter 2024 earnings announcement. The call will
begin at 7:30 a.m. CDT / 8:30 a.m. EDT on Thursday, July 25, 2024.
To listen to the call, please go to Core's website at
www.corelab.com.
Core Laboratories Inc. is a leading provider of proprietary and
patented reservoir description and production enhancement services
and products used to optimize petroleum reservoir
performance. The Company has over 70 offices in more than 50
countries and is located in every major oil-producing province in
the world. This release, as well as other statements we make,
includes forward-looking statements regarding the Company's future
revenue, profitability, business strategies and developments,
demand for the Company's products and services and for products and
services of the oil and gas industry generally, made in reliance
upon the safe harbor provisions of Federal securities law. The
Company's outlook is subject to various important cautionary
factors, including risks and uncertainties related to the oil and
natural gas industry, business and general economic conditions,
including inflationary pressures, the ability to achieve the
benefits of the redomestication of the parent company from
the Netherlands to the United States, international markets,
international political climates, including the Russia-Ukraine and the Middle East geopolitical conflicts, public
health crises, and any related actions taken by businesses and
governments, and other factors as more fully described in the
Company's most recent Forms 10-K, 10-Q and 8-K filed with or
furnished to the U.S. Securities and Exchange Commission. These
important factors could cause the Company's actual results to
differ materially from those described in these forward-looking
statements. Such statements are based on current expectations of
the Company's performance and are subject to a variety of factors,
some of which are not under the control of the Company. Because the
information herein is based solely on data currently available, and
because it is subject to change as a result of changes in
conditions over which the Company has no control or influence, such
forward-looking statements should not be viewed as assurance
regarding the Company's future performance.
The Company undertakes no obligation to publicly update or
revise any forward-looking statement to reflect events or
circumstances that may arise after the date of this press release,
except as required by law.
Visit the Company's website at www.corelab.com. Connect with
Core Lab on Facebook, LinkedIn and YouTube.
CORE LABORATORIES
INC. & SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except
per share data)
(Unaudited)
|
|
|
Three Months
Ended
|
|
|
%
Variance
|
|
|
June 30,
2024
|
|
|
March 31,
2024
|
|
|
June 30,
2023
|
|
|
vs.
Q1-24
|
|
vs.
Q2-23
|
REVENUE
|
|
$
|
130,577
|
|
|
$
|
129,637
|
|
|
$
|
127,881
|
|
|
0.7 %
|
|
2.1 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING
EXPENSES:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs of services and
product sales
|
|
|
102,930
|
|
|
|
104,588
|
|
|
|
100,295
|
|
|
(1.6) %
|
|
2.6 %
|
General and
administrative expense
|
|
|
10,259
|
|
|
|
11,789
|
|
|
|
5,811
|
|
|
(13.0) %
|
|
76.5 %
|
Depreciation and
amortization
|
|
|
3,770
|
|
|
|
3,843
|
|
|
|
3,937
|
|
|
(1.9) %
|
|
(4.2) %
|
Other (income) expense,
net
|
|
|
(2,390)
|
|
|
|
846
|
|
|
|
(1,068)
|
|
|
NM
|
|
NM
|
Total operating
expenses
|
|
|
114,569
|
|
|
|
121,066
|
|
|
|
108,975
|
|
|
(5.4) %
|
|
5.1 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING
INCOME
|
|
|
16,008
|
|
|
|
8,571
|
|
|
|
18,906
|
|
|
86.8 %
|
|
(15.3) %
|
Interest
expense
|
|
|
3,209
|
|
|
|
3,423
|
|
|
|
3,236
|
|
|
(6.3) %
|
|
(0.8) %
|
Income before income
taxes
|
|
|
12,799
|
|
|
|
5,148
|
|
|
|
15,670
|
|
|
148.6 %
|
|
(18.3) %
|
Income tax expense
(benefit)
|
|
|
3,609
|
|
|
|
1,658
|
|
|
|
(7,259)
|
|
|
117.7 %
|
|
NM
|
Net income
|
|
|
9,190
|
|
|
|
3,490
|
|
|
|
22,929
|
|
|
163.3 %
|
|
(59.9) %
|
Net income attributable
to non-controlling interest
|
|
|
158
|
|
|
|
270
|
|
|
|
83
|
|
|
NM
|
|
NM
|
Net income attributable
to Core Laboratories Inc.
|
|
$
|
9,032
|
|
|
$
|
3,220
|
|
|
$
|
22,846
|
|
|
180.5 %
|
|
(60.5) %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share
|
|
$
|
0.19
|
|
|
$
|
0.07
|
|
|
$
|
0.48
|
|
|
171.4 %
|
|
(60.4) %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share attributable to Core Laboratories Inc.
|
|
$
|
0.19
|
|
|
$
|
0.07
|
|
|
$
|
0.48
|
|
|
171.4 %
|
|
(60.4) %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted
average common shares outstanding
|
|
|
47,743
|
|
|
|
47,703
|
|
|
|
47,497
|
|
|
0.1 %
|
|
0.5 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax
rate
|
|
|
28
|
%
|
|
|
32
|
%
|
|
|
(46)
|
%
|
|
NM
|
|
NM
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SEGMENT
INFORMATION:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reservoir
Description
|
|
$
|
86,277
|
|
|
$
|
84,236
|
|
|
$
|
83,384
|
|
|
2.4 %
|
|
3.5 %
|
Production
Enhancement
|
|
|
44,300
|
|
|
|
45,401
|
|
|
|
44,497
|
|
|
(2.4) %
|
|
(0.4) %
|
Consolidated
|
|
$
|
130,577
|
|
|
$
|
129,637
|
|
|
$
|
127,881
|
|
|
0.7 %
|
|
2.1 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reservoir
Description
|
|
$
|
11,443
|
|
|
$
|
6,892
|
|
|
$
|
13,316
|
|
|
66.0 %
|
|
(14.1) %
|
Production
Enhancement
|
|
|
4,401
|
|
|
|
1,576
|
|
|
|
5,498
|
|
|
179.3 %
|
|
(20.0) %
|
Corporate and
Other
|
|
|
164
|
|
|
|
103
|
|
|
|
92
|
|
|
NM
|
|
NM
|
Consolidated
|
|
$
|
16,008
|
|
|
$
|
8,571
|
|
|
$
|
18,906
|
|
|
86.8 %
|
|
(15.3) %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
"NM" means not
meaningful
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CORE LABORATORIES
INC. & SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except
per share data)
(Unaudited)
|
|
|
|
Six Months Ended
June 30,
|
|
%
Variance
|
|
|
2024
|
|
2023
|
|
|
REVENUE
|
|
$260,214
|
|
$256,237
|
|
1.6 %
|
|
|
|
|
|
|
|
OPERATING
EXPENSES:
|
|
|
|
|
|
|
Costs of services and
product sales
|
|
207,518
|
|
201,823
|
|
2.8 %
|
General and
administrative expense
|
|
22,048
|
|
22,142
|
|
(0.4) %
|
Depreciation and
amortization
|
|
7,613
|
|
7,981
|
|
(4.6) %
|
Other (income) expense,
net
|
|
(1,544)
|
|
(1,096)
|
|
NM
|
Total operating
expenses
|
|
235,635
|
|
230,850
|
|
2.1 %
|
|
|
|
|
|
|
|
OPERATING
INCOME
|
|
24,579
|
|
25,387
|
|
(3.2) %
|
Interest
expense
|
|
6,632
|
|
6,665
|
|
(0.5) %
|
Income before income
taxes
|
|
17,947
|
|
18,722
|
|
(4.1) %
|
Income tax expense
(benefit)
|
|
5,267
|
|
(6,649)
|
|
NM
|
Net income
|
|
12,680
|
|
25,371
|
|
(50.0) %
|
Net income attributable
to non-controlling interest
|
|
428
|
|
152
|
|
NM
|
Net income attributable
to Core Laboratories Inc.
|
|
$12,252
|
|
$25,219
|
|
(51.4) %
|
|
|
|
|
|
|
|
Diluted earnings per
share
|
|
$0.26
|
|
$0.53
|
|
(50.9) %
|
|
|
|
|
|
|
|
Diluted earnings per
share attributable to Core Laboratories Inc.
|
|
$0.26
|
|
$0.53
|
|
(50.9) %
|
|
|
|
|
|
|
|
Diluted weighted
average common shares outstanding
|
|
47,662
|
|
47,476
|
|
0.4 %
|
|
|
|
|
|
|
|
Effective tax
rate
|
|
29 %
|
|
(36) %
|
|
NM
|
|
|
|
|
|
|
|
SEGMENT
INFORMATION:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
Reservoir
Description
|
|
$170,513
|
|
$163,572
|
|
4.2 %
|
Production
Enhancement
|
|
89,701
|
|
92,665
|
|
(3.2) %
|
Total
|
|
$260,214
|
|
$256,237
|
|
1.6 %
|
|
|
|
|
|
|
|
Operating
income:
|
|
|
|
|
|
|
Reservoir
Description
|
|
$18,336
|
|
$15,787
|
|
16.1 %
|
Production
Enhancement
|
|
5,977
|
|
8,779
|
|
(31.9) %
|
Corporate and
Other
|
|
266
|
|
821
|
|
NM
|
Total
|
|
$24,579
|
|
$25,387
|
|
(3.2) %
|
|
|
|
|
|
|
|
"NM" means not
meaningful
|
|
|
|
|
|
|
CORE LABORATORIES
INC. & SUBSIDIARIES
CONDENSED
CONSOLIDATED BALANCE SHEETS
(In
thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
%
Variance
|
ASSETS:
|
|
June 30,
2024
|
|
|
March 31,
2024
|
|
|
December 31,
2023
|
|
|
vs.
Q1-24
|
|
vs.
Q4-23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
17,695
|
|
|
$
|
14,913
|
|
|
$
|
15,120
|
|
|
18.7 %
|
|
17.0 %
|
Accounts receivable,
net
|
|
|
115,644
|
|
|
|
115,092
|
|
|
|
109,352
|
|
|
0.5 %
|
|
5.8 %
|
Inventories
|
|
|
69,898
|
|
|
|
70,711
|
|
|
|
71,702
|
|
|
(1.1) %
|
|
(2.5) %
|
Other current
assets
|
|
|
30,291
|
|
|
|
28,331
|
|
|
|
26,962
|
|
|
6.9 %
|
|
12.3 %
|
Total current
assets
|
|
|
233,528
|
|
|
|
229,047
|
|
|
|
223,136
|
|
|
2.0 %
|
|
4.7 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property, plant and
equipment, net
|
|
|
98,510
|
|
|
|
98,521
|
|
|
|
99,626
|
|
|
— %
|
|
(1.1) %
|
Right of use
assets
|
|
|
55,689
|
|
|
|
53,636
|
|
|
|
53,842
|
|
|
3.8 %
|
|
3.4 %
|
Intangibles, goodwill
and other long-term assets, net
|
|
|
210,072
|
|
|
|
206,746
|
|
|
|
209,791
|
|
|
1.6 %
|
|
0.1 %
|
Total assets
|
|
$
|
597,799
|
|
|
$
|
587,950
|
|
|
$
|
586,395
|
|
|
1.7 %
|
|
1.9 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
EQUITY:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
36,863
|
|
|
$
|
32,486
|
|
|
$
|
33,506
|
|
|
13.5 %
|
|
10.0 %
|
Short-term operating
lease liabilities
|
|
|
11,045
|
|
|
|
10,430
|
|
|
|
10,175
|
|
|
5.9 %
|
|
8.6 %
|
Other current
liabilities
|
|
|
49,690
|
|
|
|
42,552
|
|
|
|
44,416
|
|
|
16.8 %
|
|
11.9 %
|
Total current
liabilities
|
|
|
97,598
|
|
|
|
85,468
|
|
|
|
88,097
|
|
|
14.2 %
|
|
10.8 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt,
net
|
|
|
147,621
|
|
|
|
160,370
|
|
|
|
163,134
|
|
|
(7.9) %
|
|
(9.5) %
|
Long-term operating
lease liabilities
|
|
|
42,616
|
|
|
|
41,481
|
|
|
|
42,076
|
|
|
2.7 %
|
|
1.3 %
|
Other long-term
liabilities
|
|
|
64,270
|
|
|
|
63,214
|
|
|
|
63,281
|
|
|
1.7 %
|
|
1.6 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity
|
|
|
245,694
|
|
|
|
237,417
|
|
|
|
229,807
|
|
|
3.5 %
|
|
6.9 %
|
Total liabilities and
equity
|
|
$
|
597,799
|
|
|
$
|
587,950
|
|
|
$
|
586,395
|
|
|
1.7 %
|
|
1.9 %
|
CORE LABORATORIES
INC. & SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In
thousands)
(Unaudited)
|
|
|
|
Six Months Ended
June 30,
|
|
|
|
2024
|
|
|
2023
|
|
CASH FLOWS FROM
OPERATING ACTIVITIES:
|
|
|
|
|
|
|
Net income
|
|
$
|
12,680
|
|
|
$
|
25,371
|
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
|
|
Stock-based
compensation
|
|
|
4,688
|
|
|
|
10,337
|
|
Depreciation and
amortization
|
|
|
7,613
|
|
|
|
7,981
|
|
Deferred income
taxes
|
|
|
(777)
|
|
|
|
(10,949)
|
|
Accounts
receivable
|
|
|
(7,019)
|
|
|
|
(103)
|
|
Inventories
|
|
|
1,804
|
|
|
|
(11,213)
|
|
Accounts
payable
|
|
|
3,116
|
|
|
|
(8,685)
|
|
Other adjustments to
net income
|
|
|
571
|
|
|
|
(7,167)
|
|
Net cash provided
by operating activities
|
|
|
22,676
|
|
|
|
5,572
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM
INVESTING ACTIVITIES:
|
|
|
|
|
|
|
Capital
expenditures
|
|
|
(5,918)
|
|
|
|
(4,382)
|
|
Net proceeds on life
insurance policies and from insurance recovery
|
|
|
2,776
|
|
|
|
3,375
|
|
Other investing
activities
|
|
|
798
|
|
|
|
189
|
|
Net cash used in
investing activities
|
|
|
(2,344)
|
|
|
|
(818)
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM
FINANCING ACTIVITIES:
|
|
|
|
|
|
|
Repayment of long-term
debt
|
|
|
(38,000)
|
|
|
|
(101,000)
|
|
Proceeds from long-term
debt
|
|
|
22,000
|
|
|
|
111,000
|
|
Dividends
paid
|
|
|
(938)
|
|
|
|
(934)
|
|
Repurchase of common
shares
|
|
|
(206)
|
|
|
|
(200)
|
|
Equity related
transaction costs
|
|
|
(594)
|
|
|
|
(2,553)
|
|
Other financing
activities
|
|
|
(19)
|
|
|
|
(291)
|
|
Net cash provided
by (used in) financing activities
|
|
|
(17,757)
|
|
|
|
6,022
|
|
|
|
|
|
|
|
|
NET CHANGE IN CASH AND
CASH EQUIVALENTS
|
|
|
2,575
|
|
|
|
10,776
|
|
CASH AND CASH
EQUIVALENTS, beginning of period
|
|
|
15,120
|
|
|
|
15,428
|
|
CASH AND CASH
EQUIVALENTS, end of period
|
|
$
|
17,695
|
|
|
$
|
26,204
|
|
Non-GAAP Information
Management believes that the exclusion of certain income and
expenses enables it to evaluate more effectively the Company's
operations period-over-period and to identify operating trends that
could otherwise be masked by the excluded Items. For this
reason, management uses certain non-GAAP measures that exclude
these Items and believes that this presentation provides a clearer
comparison with the results reported in prior periods. The non-GAAP
financial measures should be considered in addition to, and not as
a substitute for, the financial results prepared in accordance with
GAAP, as more fully discussed in the Company's financial statements
and filings with the Securities and Exchange Commission.
Reconciliation of
Operating Income, Net Income and Diluted Earnings Per Share
Attributable to Core Laboratories Inc.
(In thousands, except
per share data)
(Unaudited)
|
|
|
|
Operating
Income
|
|
|
|
Three Months
Ended
|
|
|
|
June 30,
2024
|
|
|
March 31,
2024
|
|
|
June 30,
2023
|
|
GAAP
reported
|
|
$
|
16,008
|
|
|
$
|
8,571
|
|
|
$
|
18,906
|
|
Stock compensation
(1)
|
|
|
—
|
|
|
|
3,458
|
|
|
|
(934)
|
|
Loss on lease
abandonment and assets write-down (2)
|
|
|
—
|
|
|
|
1,809
|
|
|
|
—
|
|
Severance
costs
|
|
|
—
|
|
|
|
824
|
|
|
|
—
|
|
Gain on life insurance
policies (3)
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,965)
|
|
Foreign exchange losses
(gains)
|
|
|
388
|
|
|
|
285
|
|
|
|
(386)
|
|
Excluding specific
items
|
|
$
|
16,396
|
|
|
$
|
14,947
|
|
|
$
|
15,621
|
|
|
|
|
|
|
Net Income
Attributable to Core Laboratories Inc.
|
|
|
|
Three Months
Ended
|
|
|
|
June 30,
2024
|
|
|
March 31,
2024
|
|
|
June 30,
2023
|
|
GAAP
reported
|
|
$
|
9,032
|
|
|
$
|
3,220
|
|
|
$
|
22,846
|
|
Stock compensation
(1)
|
|
|
—
|
|
|
|
2,766
|
|
|
|
(747)
|
|
Loss on lease
abandonment and assets write-down (2)
|
|
|
—
|
|
|
|
1,447
|
|
|
|
—
|
|
Severance
costs
|
|
|
—
|
|
|
|
659
|
|
|
|
—
|
|
Gain on life insurance
policies (3)
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,572)
|
|
Foreign exchange losses
(gains)
|
|
|
310
|
|
|
|
229
|
|
|
|
(309)
|
|
Reversal of net
deferred tax liabilities and/or effect of higher (lower) tax rate
(4)
|
|
|
1,050
|
|
|
|
628
|
|
|
|
(10,394)
|
|
Excluding specific
items
|
|
$
|
10,392
|
|
|
$
|
8,949
|
|
|
$
|
9,824
|
|
|
|
|
|
|
|
|
|
Diluted Earnings Per
Share Attributable to Core Laboratories Inc.
|
|
|
|
Three Months
Ended
|
|
|
|
June 30,
2024
|
|
|
March 31,
2024
|
|
|
June 30,
2023
|
|
GAAP
reported
|
|
$
|
0.19
|
|
|
$
|
0.07
|
|
|
$
|
0.48
|
|
Stock compensation
(1)
|
|
|
—
|
|
|
|
0.06
|
|
|
|
(0.02)
|
|
Loss on lease
abandonment and assets write-down (2)
|
|
|
—
|
|
|
|
0.03
|
|
|
|
—
|
|
Severance
costs
|
|
|
—
|
|
|
|
0.01
|
|
|
|
—
|
|
Gain on life insurance
policies (3)
|
|
|
—
|
|
|
|
—
|
|
|
|
(0.03)
|
|
Foreign exchange losses
(gains)
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
—
|
|
Reversal of net
deferred tax liabilities and/or effect of higher (lower) tax rate
(4)
|
|
|
0.02
|
|
|
|
0.01
|
|
|
|
(0.22)
|
|
Excluding specific
items
|
|
$
|
0.22
|
|
|
$
|
0.19
|
|
|
$
|
0.21
|
|
|
|
|
|
|
|
|
|
|
|
(1) Three months
ended March 31, 2024 includes the acceleration of stock
compensation expense associated with employees reaching eligible
retirement age. Three months ended June 30, 2023 include reversals
of stock compensation expense previously recognized due to a change
in probability of performance condition for certain executive's
share awards recorded in G&A expenses.
|
|
(2) Three months
ended March 31, 2024 include the write-down of leasehold
improvements, right of use assets and/or other assets and exit
costs associated with consolidation of certain
facilities.
|
|
(3) Three months
ended June 30, 2023 includes gain on life insurance policies death
benefit proceeds recorded in G&A expenses.
|
|
(4) Three months
ended June 30, 2024 and March 31, 2024 includes the effect to
reflect tax expense at a normalized rate of 20%. Three months ended
June 30, 2023 includes the reversal of certain net deferred tax
liabilities which will not be realized as a result of the
Redomestication Transaction and the effect to reflect tax expense
at a normalized rate of 20%.
|
|
Segment
Information
(In
thousands)
(Unaudited)
|
|
|
|
Operating
Income
|
|
|
|
Three Months Ended
June 30, 2024
|
|
|
|
Reservoir
Description
|
|
|
Production
Enhancement
|
|
|
Corporate and
Other
|
|
GAAP
reported
|
|
$
|
11,443
|
|
|
$
|
4,401
|
|
|
$
|
164
|
|
Foreign exchange losses
(gains)
|
|
|
346
|
|
|
|
114
|
|
|
|
(72)
|
|
Excluding specific
items
|
|
$
|
11,789
|
|
|
$
|
4,515
|
|
|
$
|
92
|
|
Return on Invested Capital
Return on Invested Capital ("ROIC") is presented based on
management's belief that this non-GAAP measure is useful
information to investors and management when comparing
profitability and the efficiency with which capital has been
employed over time relative to other companies. The Board has
established an internal metric to demonstrate ROIC performance
relative to the oilfield service companies listed as Core's Comp
Group by Bloomberg. ROIC is not a measure of financial performance
under GAAP and should not be considered as an alternative to net
income.
ROIC of 8.0% is defined by Bloomberg as Net Operating Profit
After Tax ("NOPAT") of $32.4 million
divided by Average Total Invested Capital ("Average TIC") of
$406.9 million where NOPAT is defined
as GAAP net income before non-controlling interest plus the sum of
income tax expense, interest expense, and pension expense less
pension service cost and tax effect on income before interest and
tax expense for the last four quarters. Average TIC is defined as
the average of beginning and ending periods' GAAP stockholders'
equity plus the sum of net long-term debt, lease liabilities,
allowance for credit losses, net of deferred taxes, and income
taxes payable.
Free Cash Flow
Core uses the non-GAAP financial measure of free cash flow to
evaluate its cash flows and results of operations. Free cash flow
is an important measurement because it represents the cash from
operations, in excess of capital expenditures, available to operate
the business and fund non-discretionary obligations. Free cash flow
is not a measure of operating performance under GAAP and should not
be considered in isolation nor construed as an alternative
consideration to operating income, net income, or cash flows from
operating, investing, or financing activities, each as determined
in accordance with GAAP. Free cash flow should not be considered a
measure of liquidity. Moreover, since free cash flow is not a
measure determined in accordance with GAAP and thus is susceptible
to varying interpretations and calculations, free cash flow as
presented may not be comparable to similarly titled measures
presented by other companies.
Computation of Free
Cash Flow
(In
thousands)
(Unaudited)
|
|
|
|
Three Months
Ended
|
|
|
Six Months
Ended
|
|
|
|
|
June 30,
2024
|
|
|
June 30,
2024
|
|
|
Net cash provided by
operating activities
|
|
$
|
17,146
|
|
|
$
|
22,676
|
|
|
Capital
expenditures
|
|
|
(2,866)
|
|
|
|
(5,918)
|
|
|
Free cash
flow
|
|
$
|
14,280
|
|
|
$
|
16,758
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/core-lab-reports-second-quarter-2024-results-302205824.html
SOURCE Core Laboratories Inc